Success Metrics

Clinical Success Rate
77.8%

Based on 35 completed trials

Completion Rate
78%(35/45)
Active Trials
0(0%)
Results Posted
69%(24 trials)
Terminated
10(19%)

Phase Distribution

Ph phase_4
21
40%
Ph not_applicable
4
8%
Ph phase_2
9
17%
Ph phase_1
2
4%
Ph phase_3
15
28%

Phase Distribution

2

Early Stage

9

Mid Stage

36

Late Stage

Phase Distribution51 total trials
Phase 1Safety & dosage
2(3.9%)
Phase 2Efficacy & side effects
9(17.6%)
Phase 3Large-scale testing
15(29.4%)
Phase 4Post-market surveillance
21(41.2%)
N/ANon-phased studies
4(7.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

35 of 49 finished

Non-Completion Rate

28.6%

14 ended early

Currently Active

0

trials recruiting

Total Trials

53

all time

Status Distribution
Active(1)
Completed(35)
Terminated(14)
Other(3)

Detailed Status

Completed35
Terminated10
Withdrawn4
unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
53
Active
0
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (3.9%)
Phase 29 (17.6%)
Phase 315 (29.4%)
Phase 421 (41.2%)
N/A4 (7.8%)

Trials by Status

unknown36%
withdrawn48%
not_yet_recruiting12%
terminated1019%
completed3566%

Recent Activity

Clinical Trials (53)

Showing 20 of 53 trialsScroll for more
NCT07382843Phase 4

Melatonin Agonist for Shift-time Workers.

Completed
NCT06512363Phase 3

A Study of Ramelteon in Chinese Patients With Chronic Insomnia

Not Yet Recruiting
NCT03931070Phase 4

The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU

Completed
NCT02691013Not Applicable

The Impact of Ramelteon on Sleep and Delirium in Patients Who Undergo Pulmonary Thromboendarterectomy (PTE) Surgery

Unknown
NCT03265951Phase 4

Ramelteon for Complex Insomnia in Veterans With PTSD

Withdrawn
NCT02324153Phase 2

Ramelteon in the Prevention of Post-operative Delirium

Completed
NCT03165695Phase 4

Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults

Withdrawn
NCT02560324Phase 2

Effect of Ramelteon on Smoking Abstinence

Completed
NCT00642694Phase 3

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon

Terminated
NCT02669082Phase 4

The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy

Completed
NCT02564939Phase 4

Ramelteon Prevention of Delirium - RCT

Unknown
NCT02840591Phase 4

Ramelteon and Citicoline for Delirium

Withdrawn
NCT00325728Phase 2

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Completed
NCT00753623Not Applicable

Clinical Management of Neuropathic Pain With Ramelteon

Terminated
NCT02153086

Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -

Completed
NCT00539110Phase 2

Differential Effects of Zolpidem Versus Ramelteon in Burned Children

Completed
NCT02058992

Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty

Completed
NCT00414102Phase 4

Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.

Completed
NCT01677182Phase 3

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Terminated
NCT02156271Phase 4

Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance

Completed

Drug Details

Intervention Type
DRUG
Total Trials
53